Abstract
Using an imbalanced panel of over 2,372 firms, in this chapter, we have examined the determinants of the profitability of Indian Pharmaceutical firms for the period 1991–2005. Our study indicates that industrial structure does not favorably create any entry barrier for firms to insulate its high profit earning from the incumbents. The analysis also indicates that firm-specific strategies like marketing or R&D intensity do not have any favorable impact on the profitability of firms. However, the interaction between R&D and marketing is one of the most successful strategies for firms. In other words, if firms can come out with new products that have some therapeutic qualities and successfully market the product , they can earn higher profit. We also find that firms that have more niche products under their commands are more profitable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
In our book, we have, however, measured the efficiency and productivity of firms in value terms. In a sense, the productivity and efficiency measures of firms are revenue earned per unit of input expenditure incurred by firms. Consequently, the efficiency and productivity of firms are also influenced by the prices for the product or the demand side factors. However, there was no consideration for the cost of production in our efficiency or productivity related analysis.
- 2.
In the spirit of efficiency analysis one could also compute the profit efficiency of the firms. However, in the context of our study, there are two major difficulties in estimating the profit efficiency of firms. The first is the non-availability of data on input and output prices at the firm level. The second is conceptual; in particular, the framework for profit efficiency is developed in a competitive scenario where firm faces competitive input and output prices. Apart from incorporating technical efficiency, one has to take into consideration the allocative efficiency while estimating the profit efficiency of a firm. The question of allocative efficiency arises because firms try to produce their output and employ factors of production in light of the prevailing market prices and in accordance with the marginalist principle while they maximize their profit. Thus, a firm is profit efficient when it is technically as well as allocatively efficient. However, in a monopolistic market it is optimal for a firm to remain allocatively inefficient in the product market. If a firm is monopsonist, it also remains allocatively inefficient even in the input market. Though competitive, the Indian pharmaceutical industry resembles a differentiated monopolistic market condition and firms have some degrees of market power for various product groups. Consequently, for a profit-maximizing firm it is optimal to remain allocatively inefficient. It, therefore, makes little sense to compute the profit efficiency of firms.
- 3.
Porter has also suggested that the simultaneous pursuit of both strategies is not possible on the ground that each of these involves a different set of resources and organization arrangements. Firms should therefore emphasize any one of the generic strategies instead of getting “stuck-in-the-middle”, which is characterized as a lack of distinctive emphasis on any particular strategy.
- 4.
- 5.
See Hay and Morris (1991), pp. 236–239 for an excellent review on this issue.
- 6.
The price for plant and machinery is taken as a proxy for capital goods
- 7.
While computing the output efficiency of firms, we noticed that firms capturing 75% of the market share are the most efficient firms in the industry with an average efficiency of around 75 to about 80%. Further, the total number of firms from this group is consistent over the years and varies from 25 to 30.
- 8.
We have also considered different lag length in our model. However, there are no qualitative differences in our estimated result.
- 9.
Insights about the marketing and R&D strategy of the firms were gained during our field survey.
- 10.
While conducting profitability analysis, it is necessary to check for the possible presence of simultaneity among the dependent and the independent variables. The presence of simultaneity may arise specifically for the firm specific strategic variables and the profit margin of firms, because optimum-spending R&D, marketing and the profit margin of firms are derived simultaneously as a profit maximization exercise of firms. Further, there can bi-directional causality between the profitability in an industry and the structure of the industry (see, Martin 2002; Hay and Morris 1991 for a theoretical discussion on this issue) Disregarding such simultaneous relationship between the profit margin of firms and its R&D or advertisement or trade relationship may lead to the serious problem of simultaneity bias. In the context of our study, we have conducted the Hausman test for simultaneity taking into consideration all industry specific structural variables as well as firm specific strategic variables like marketing intensity, R&D intensity, export intensity. The result of the Hausman test, however, rules out any simultaneity among the variables considered in our model. Therefore, given the data point and the time framework for which we are conducting our analysis we do not notice any presence of endogenity among variables.
- 11.
While calculating the age of the firms, we noticed that 27 new companies have entered the market between 1995 and 2002.
- 12.
We have mentioned that we have tried different lag lengths like 2, 3, 4 and even 5 years lag length. However, there are no qualitative differences in our estimated results.
References
Amel D, Froeb L (1991) Do firms differ much? Journal of Industrial Economics 39(3):323–31
Apte PG, Vaidynathan R (1982) Concentration, controls and performance in 29 manufacturing industries in India. Indian Economic Review 17:241–64
Bain J (1956) Barrier to new competition. Harvard University Press, Cambridge, MA
Bain J (1951) Relation of profit rate to industry concentration: American manufacturing, 1936–1940. Quaterly Journal of Economics 65:293–324
Baldwin JR, Gorecki PK (1985) The determinants of small plant market share in Canadian manufacturing industries in the 1970s. Review of Economics and Statistics 67:156–161
Bardburd RM, Caves RE (1982) A closer look at the effect of market growth on industries’ profits. Review of Economics and Statistics 64:635–42
Brozen Y (1971) Bain’s concentration and rates of return revisited. Journal of Law and Economics 14:351–369
Calfee JE (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing 21:174–93
Carter J (1977) In search of synergy: a structure-performance test. Review of Economics and Statistics 59:279–89
Catherine M (1999) Market structure, R&D and advertisement in the pharmaceutical industry. The Journal of Industrial Economics 12(2):169–194
Caves RE, Khalizadeh-Shirazi J, Porter ME (1975) Scale economies in statistical analyses of market power. Review of Economics and Statistics 57:133–140
Chakroborty S (1995) Issues in industrial economics. Avebury Publishing, Brookfield.
Chhibber PK, Majumdar SK (1999) Foreign ownership and profitability. J Law Econ, University of Chicago Press, 42(1):209–38
Chou TC (1986) Concentration, profitability and trade in a simultaneous equation analysis: the case of Taiwan. Journal of Industrial Economics 34:429–443
Collins NR, Preston LE (1968) Concentration and price-cost margins in manufacturing industries. University of California Press, Berkeley
Collins NR, Preston LE (1969) Price-cost margins and industry structure. Review of Economics and Statistics 51:271–286
Comanor WS, Wilson TA (1967) Advertising, market structure and performance. Review of Economics and Statistics 49:423–440
Commanor WS (1986) The political economy of the pharmaceutical industry. Journal of Economic Literature 24:1187–1217
Cowling K (1976) On the theoretical specification of industrial structure-performance relationships. European Economic Review 8:1–14
Cowling K, Waterson M (1976) Price-cost margins and market structure. Economica 43:267–274
Cubbin J, Geroski PA (1987) The convergence of profits in the long run: inter-firm and inter-industry comparisons. Journal of Industrial Economics 35:427–42
Demsetz H (1974) Two systems of belief about monopoly. In: Goldschmid HJ, Mann HM, Weston JF (eds) Industrial concentration: the new learning. Little-Brown, Boston, pp 74–85
Eaton BC, Lipsey RG (1978) Freedom of entry and the existence of pure profit. Economic Journal 88:455–56
Stigler GF (1968) Price and non-price competition. J Pol Econ, University of Chicago Press, 76:149–165
Geroski P, van Reenen J, Walters CF (1997) How persistently do firms innovate? Research Policy 26(1):33–48
Grabowski HG, Mueller DC (1978) Industrial research and development, intangible capital stocks, and firm profit rates. Bell Journal of Economics 9:328–343
Gupta V (1983) A simultaneous determination of structure conduct and performance in Canadian manufacturing. Oxford Economic Paper 35:281–301
Hausman JA (1978) Specification tests in econometrics. Econometrica 46:1251–1271
Hay DA, Morris D (1991) Industrial economics and organization. Oxford University Press, New York
Hurwitz MA, Caves RE (1988) Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. Journal of Law and Economics 31(2):299–320
Jacquemin A, de Ghellinck E, Huveneers C (1980) Concentration and profitability in a small, open economy. Journal of Industrial Economics 29:131–144
Kessides IN (1986) Advertising, sunk costs, and barriers to entry. Rev Econ Stat 68:84–95.
Kessides IN (1987) Do firms differ much? Some additional evidence, mimeo. University of Maryland.
Kumar N (1990) Mobility Barriers and Profitability of Multinational and Local Enterprises in Indian Manufacturing. Journal of Industrial Economics 38(4):449–63
KPMG (2006) The Indian pharmaceutical industry: collaboration for growth.
Kwoka JE Jr (1981) Does the Choice of Concentration Measure Really Matter? Journal of Industrial Economics 29:445–453
Lustgarten SH (1975) The impact of buyer concentration in manufacturing industry. Rev Econ Stat 478 57:125–132.
Majumdar SK (1998) Slack in the State-owned Enterprises: An Evaluation of the Impact of Soft-Budget Constraints. International Journal of Industrial Organization 16(3):377–394
Mansfield E (1983) Technological change and Market Structure: An Empirical Study American Economic Review 73:205–09
Martin S (1979a) Advertising, Concentration and Profitability: The Simultaneity Problem. Bell Journal of Economics 10:639–647
Martin S (1979b) Entry Barriers, Concentration and Profit. Southern Economic Journal 46:471–488
Martin S (2002) Advanced Industrial Economics Oxford UK Blackwell Publisher.
Mason, E (1939) ‘Price and production policies of large-scale enterprises’, American economic Review 29(Suppl.29) pp 61–74.
McGahan AM (1999) The performance of U.S. corporations: 1981–1994. J Ind Econ 47:373–398.
Nakao T (1979) Profit Rates and Market Share of leading Industrial Firms in Japan. Journal of Industrial Economic 2:371–83
Narayana and Joseph (1993) Industry and Trade Liberalisation: Performance of Motor Vehicles and Electronics Industries, 1981–91, Economic and Political Weekly (EPW), Vol. 28, No. 8/9, Feb. 20–27, pp. M13–M20.
Nerlove M, Arrow KJ (1962) Optimal advertisement policy under dynamic condition. Economica 573 29:129–142.
Neumann M, Bobel I, Haid A (1979) 'Profitability. Risk and Market Structure in West German Industries', Journal of Industrial Economics 27:227–242
Neumann M, Bobel I, Haid A (1985) Domestic Concentration, Foreign Trade and Economic Performance. International Journal of Industrial Organization 3:1–19
Porter M (1980), Competitive Strategies: Technique for Analyzing Industries and Companies, Free school New York.
Porter M (1985) Competitive Advantage: Creating and Sustaining superior performance, Free school New York.
Röller, L H and B Sinclair-Desgagn´e (1996) ‘On the Heterogeneity of Firms’, European Economic Review, 40, 531–539
Rumelt, R P, D Schendel and D J Teece (1991) ‘Strategic management and economics’. Strategic Management Journal. 12 (Winter Special Issue) 5–29
Santerre RE, Stephen PN (2004) Health economies: theories, insights and industry studies, 3rd 700 edn. South-Western, Mason.
Saving TR (1970) Concentration Ratios and the Degree of Monopoly. International Economic Review 11:139–146
Sawhney PK, Sawhney BL (1973) Capacity Utilization, Concentration and Price Cost Margins: Results on Indian Industries. Journal of Industrial Economics 21(2):145–153
Scherer FM and D Ross (1990), Industrial Market Structure and Economic performance (3rd edn) Huognton Mifflin: Boston, MA.
Schmalensee R (1989) Inter-Industry Studies of Structure and Performance. In: Schmalensee R, Willig R (eds) Handbook of Industrial Organization, vol 2. North-Holland, Amsterdam, pp 951–1009
Schweitzer SO (1997) Pharmaceutical Economics and Policy, Oxford University Press. University Press, New York
Scott JT, Pascoe G (1986) Beyond Firm and Industry Effects on Profitability in Imperfect Markets. Review of Economics and Statistics 68:284–292
Scott-Morton F (1999) Entry decision in the generic drug industry. Rand J Econ 30:421–440.
Sen G (1992) ‘Margin, Costs and Competition: The Tyre Industry in 1974-83’ in A Ghosh, K K Subrahmaniam M Eapen and H. A. Drabu (eds) Indian Industralization: Structure and Policy Issues, Delhi: Oxford University Press
Shepherd WG (1974) The Treatment of Market Power. Columbia University Press, New York
Stigler GJ (1964) A Theory of Oligopoly. Journal of Political Economy 72:44–61
Stimpert JL, Dunhaime IM (1997) Seeing the Big Picture: The influence of Industry, Diversification and Business Strategy on Performance. Academy of Management Journal 40(3):560–583
Strickland AD, Weiss LW (1976) Advertising, Concentration and Price–cost Margins. Journal of Political Economy 84:1109–1121
Teece D. J. (1980) ‘Economics of Scope and Scope of the Enterprises’ Journal of Economic Behavior and Organization, (1), 223–247.
Teece DJ (1982) Towards the Economic Theory of the Multi-product Firm. Journal of Economic Behavior and Organization 3(1):39–63
Viscusi, W K, M J Vernon and J E Harrington (2000) The Economies and Regulation and Antitrust. Mit Press, Cambridge, third edition.
Weiss LW (1969) Advertising, Profits, and Corporate Taxes. Review of Economics and Statistics 51:421–430
Weiss, L W (1976) 'Optimal Plant Size and the Extent of Suboptimal Capacity', in: R.T. Masson and P.E. Qualls, eds., Essays in Honor of Joe S. Bain. Cambridge: Ballinger.
Williamson OE (1967) The economics of discretionary behaviour. Chicago University Press, 816 Chicago.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mazumdar, M. (2013). Profitability of Indian Pharmaceutical Firms. In: Performance of Pharmaceutical Companies in India. Contributions to Economics. Physica, Heidelberg. https://doi.org/10.1007/978-3-7908-2876-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-7908-2876-4_6
Published:
Publisher Name: Physica, Heidelberg
Print ISBN: 978-3-7908-2875-7
Online ISBN: 978-3-7908-2876-4
eBook Packages: Business and EconomicsBusiness and Management (R0)